KALA BIO, Inc.KALA

$3.61+0.76 (+26.67%)

NASDAQHealthcare24:00 UTC

Company snapshot

Market Cap

$29M

Micro-cap

-100%

2017 — today

10-Year Price

-100%

2017 — today

52-Week Range

$2.06$981.50

Current $3.61· 0%

Kala Bio, Inc. functions as a biopharmaceutical company dedicated to the creation and commercialization of new therapeutic solutions. The core of their strategy involves utilizing proprietary nanoparticle technology, specifically mucus penetrating particles (MPPs). Initially, their focus for these treatments is directed towards ophthalmic diseases. The company was established in 2009 by co-founders Justin Hanes, Robert S. Langer, and Colin R. Gardner, and its headquarters are located in Arlington, Massachusetts.

Valuation in context

P/E ratio

-1.2

N/A

Not meaningful — company is unprofitable

P/B ratio

2.7

Historically cheap

Historically cheap relative to the last 10 years

FCF Yield

-88.6%

Near historic low

Near historic low — last 10 years

Free · No credit card needed

Get alerted when KALA is cheap

Set a free alert — we'll push you when P/E, yield, or other metrics cross a historical threshold.